12
Mar

Food allergy upstart Allergen Research Corporation raised an $80 million B round to get its lead candidate into late-stage development, pushing ahead with a treatment for peanut allergies.

…read more

Source: Allergy biotech hauls in $80M for its oral immunotherapy

    

0 No comments